Skip to main content
Premium Trial:

Request an Annual Quote

GE Healthcare Will Distribute Gene Logic s Expression-Analysis System ...

NEW YORK, July 19 (GenomeWeb News) - GE Healthcare will be the global distributor for Gene Logic's Sciantis online gene expression-analysis system, Gene Logic said today.

 

News of the deal caused shares in Gene Logic to climb 7.7 percent, or $.28, to $3.96 in heavy mid-afternoon trading today.The stock briefly reached $4.21 in late-morning trade but leveled off soon after.

 

Under the terms of the agreement, GE Healthcare will distribute Sciantis in 32 countries, and will be the exclusive distributor in Japan.

 

Financial terms of the deal were not disclosed.

 

Gene Logic said that Sciantis was developed for use by researchers in academia, government, and research organizations. The browser-based gene-expression application, based on Gene Logic's gene-expression reference database, enables researchers to profile the expression of more than 6,000 human, rat, and mouse genes in normal and diseased tissue, Gene Logic said.

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.